An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification

Vaccine

Volumn 23, Issue 15 SPEC. ISS., 2005, Pages 1833-1837

  Pujol, Merardo ^a   Ramírez, Nadia I ^a   Ayala, Marta ^a   Gavilondo, Jorge V ^a   Valdés, Rodolfo ^a   Rodríguez, Meilyn ^a   Brito, José ^a   Padilla, Sigifredo ^a   Gómez, Leonardo ^a   Reyes, Biunaiky ^a   Peral, Rudy ^a   Pérez, Marlene ^a   Marcelo, José L ^a   Milá, Lorely ^a   Sánchez, Rafael F ^a   Páez, Rolando ^a   Cremata, José A ^a   Enríquez, Gil ^a   Mendoza, Otto ^a   Ortega, Mercedes ^a   Borroto, Carlos ^a   more..

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Plant; Plantibody; scFv; Transgenic

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY; PLANT EXTRACT; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VACCINE;

CONFERENCE PAPER; DRUG PURIFICATION; PLANT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCALE UP; TRANSGENIC PLANT;

EID: 20044376094     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.11.023     Document Type: Conference Paper

References (32)

1. Stieger M. Versuche zur Integration und Expression chimärer Immunglobuline in Pflanzen. Ph.D. Thesis, Universität Köln, FRG, 1987.
2. Düring K. Wundinduzierbare Expression und Sekretion von T4 Lysozym und Monoklonalen Antikörpern in Nicotiana tabacum. Ph.D. Thesis, Universität Köln, FRG, 1988.
3. A.H. Hiatt, R. Cafferkey, and K. Bowdish Production of antibodies in transgenic plants Nature 342 1989 76 78
4. H. Daniell, S.J. Streatfield, and K. Wycoff Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants Trends Plant Sci 6 8 2001 219 226
5. A. Mallik, G.S. Pinkus, and S. Sheffer Biopharma's capacity crunch The McKinsey Quarterly Special Edition: Risk and Resilience 2002 p. 9-11
6. Mayer S. Who's involved? In: Non-food GM crops: new dawn or false hope? GeneWatch, Derbyshire, UK; 2003. p. 11-3.
7. E. López, B.E. Acevedo, R. Silva, B. Tormo, R. Montero, and L. Herrera Development of Cuban biotechnology J Commercial Biotechnol 9 2 2003 147 152
8. E. Pentón, V. Muzio, and M. González-Griego The hepatitis B virus (HBV) infection and its prevention by a recombinant-DNA surface antigen (rec-HBsAg) vaccine Biotecnología Aplicada 11 1 1994 1 11
9. A. Agraz, C. Duarte, and L. Costa Immunoaffinity purification of recombinant Hepatitis B surface antigen from yeast using a monoclonal antibody J. chromatogr A 672 1994 25 33
10. G.M. Fontirrochi, M. Dueñas, and M.E. Fernández de Cossio A mouse hybridoma cell line secreting IgG and IgM with specificity for the hepatitis B surface antigen Biotecnología Aplicada 10 1993 24 30
11. C.F.M. Hendriksen A call for a European prohibition of monoclonal antibody (mAb) production by the ascites procedure in laboratory animals ATLA 26 1998 523 540
12. R. Valdés, N. Ibarra, and M. González CB.Hep-1 hybridoma growth and antibody production using protein-free medium in a hollow fiber bioreactor Cytotechnology 35 2 2001 145 154
13. M. Ayala, R.F. Balint, M.E. Fernández de Cossio, L. Cannán-Haden, J. Larrick, and J.V. Gavilondo Variable region sequence modulates periplasmic export of a single chain Fv antibody fragment in E. coli Biotechniques 18 1995 832 842
14. N. Ramírez, P. Oramas, and M. Ayala Expression of a single-chain Fv antibody fragment specific for the Hepatitis B surface antigen in transgenic tobacco plants Transgenic Res 11 2002 61 64
15. I. Pedroso, A. Agraz, and J. Brito Immunoaffinity purification of a particulate recombinant HBsAg using single-chain Fv antibody fragments Minerva Biotecnológica 9 1997 68 75
16. L. Sánchez, M. Ayala, and F. Freyre High cytoplasmic expression in E. coli, purification, and in vitro refolding of a single chain Fv antibody fragment against the Hepatitis B surface antigen J Biotechnol 72 1999 13 20
17. N. Ramírez, P. Oramas, M. Ayala, M. Rodríguez, M. Pérez, and J.V. Gavilondo Expression and long-term stability of a recombinant single-chain Fv antibody fragment in transgenic Nicotiana tabacum seeds Biotechnol Lett 23 1 2001 47 49
18. U. Fiedler, and U. Conrad High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds Bio/Technology 13 1995 1090 1093
19. N. Ramirez, D. Lorenzo, D. Palenzuela, L. Herrera, M. Ayala, and A. Fuentes Single-chain antibody fragments specific to the hepatitis B surface antigen, produced in recombinant tobacco cell cultures Biotechnol Lett 2002 1233 1236
20. N. Ramírez, M. Rodriguez, and M. Ayala Expression and characterization of an anti-Hepatitis B surface antigen glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen Biotechnol Appl Biochem 38 2003 223 230
21. P. Lerouge, M. Cabanes-Macheteau, C. Rayon, A.C. Fischette-Laine, V. Gomord, and L. Faye N-glycoprotein biosynthesis in plants: recent developments and future trends Plant Mol Biol 38 1-2 1998 31 48
22. K. Ko, Y. Tekoah, and P.M. Rudd Function and glycosylation of plant-derived antiviral monoclonal antibody Proc Natl Acad Sci USA 100 2003 8013 8018
23. J. Nuttall, N. Vine, J.L. Hadlington, P. Drake, L. Frigerio, and J.K.-C. Ma ER-resident chaperone interactions with recombinant antibodies in transgenic plants Eur J Biochem 269 24 2002 6042 6051
24. M. Bardor, L. Faye, and P. Lerouge Analysis of the N-glycosylation of recombinant glycoproteins produced in transgenic plants Trends Plant Sci 4 1999 376 380
25. J. Thömmes, M. Halfar, S. Lenz, and M. Kula Purification of monoclonal antibodies from whole hybridoma fermentation broth by fiuidized bed adsorption Biotechnol Bioeng 45 1995 203 211
26. R. Valdés, L. Gómez, and S. Padilla Large-scale purification of an antibody directed against hepatitis surface antigen from transgenic tobacco plants Biochem Biophys Res Commun 308 2003 94 100
27. R. Valdés, B. Reyes, and T. Alvarez Hepatitis B surface antigen immunopurification using plant-derived specific antibody produced in large scale Biochem Biophys Res Commun 310 2003 742 747
28. M.L. Yarmush, K.P. Antonsen, S. Sundaram, and D.M. Yarmush Immunoadsorption: strategies for antigen elution and production of reusable adsorbents Biotechnol Prog 8 3 1992 168 178
29. M.E. Fernández de Cossio, R. Valdés, and A. Agraz Development of mouse monoclonal antibody for the purification of a yeast-derived recombinant hepatitis B surface antigen Minerva Biotechnologica 9 1997 76 84
30. Centro para el Control Estatal de la Calidad de los Medicamentos (CECMED), Cuba. Requisitos a presentar para la información química-farmacéutica y biológica de productos farmacéuticos obtenidos a partir de plantas transgénicas. Proyecto, 2003.
31. European Agency for the Evaluation of Medicinal Products (EMEA). Points to consider on the quality aspects of medicines containing active substances produced by stable transgene expression in higher plants. Draft CPMP/BWP/764/02, 2002.
32. Food and Drug Administration (FDA), USA. Guidance for Industry. Drugs, Biologics, and Medical Devices Derived from Bioengineered Plants for Use in Humans and Animals. Draft guidance, 2002.